LIMN (LIMINATUS PHARMA INC.) is held by 10 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($116,465), GEODE CAPITAL MANAGEMENT, LLC ($20,249), JANE STREET GROUP, LLC ($12,259). Net institutional sentiment: Mixed.
See how LIMN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer